MEĐUNARODNI SEMINAR
Novine u lečenju bolesti bubrega: dijabetesna nefropatija
i nefrolitijaza, od prevencije do transplantacije
(Advancements in the treatment of kidney diseases: diabetic nephropathy and nephrolithiasis, from prevention to transplantation)
Zajednički seminar Medicinskog fakulteta u Univerziteta u Beogradu i Mayo Clinic, Rochester, Minnesota, USA
Obaveštavamo nastavnike, saradnike i studente da će se na našem fakultetu 5. juna 2024. godine, održati zajednički seminar Medicinskog fakulteta u Univerziteta u Beogradu i Mayo Clinic, Rochester, Minnesota, USA.
Ovaj značajni naučni skup je pretkonferencijskim seminar 14th Serbian Diaspora Medical Conference 2024, čiji je jedan od organizatora Medicinski fakultet Univerziteta u Beogradu, a pokrovitelj Fondacija NJ.K.V. Princeze Katarine.
Seminar je akreditovan sa 7 bodova za polaznike.
Pozivamo sve zainteresovane da svojim prisustom doprinesu uspehu ovog skupa i jačanju veza između Medicinskog fakulteta u Univerziteta u Beogradu i Mayo Clinic, Rochester, Minnesota, USA
Wednesday, 5th June 2024
Venue: Medical Faculty, University in Belgrade
Pre-Conference Session:
ADVANCEMENTS IN THE TREATMENT OF KIDNEY DISEASES:
DIABETIC NEPHROPATHY AND NEPHROLITHIASIS,
FROM PREVENTION TO TRANSPLANTATION
Session: DIABETES AND COMPLICATION IN ASSOCIATION WITH THE MAYO CLINIC: DIABETIC NEPROPATHY AND RENAL TRANSPLANTATION
Session chairs: Lazar Davidovic (Serbia), Vesna D. Garovic (USA) Nebojsa M. Lalic (Serbia)
09.00–10.00 Registration of the participants
10.00-10.05 Welcome and dean’s address
Lazar Davidovic (Belgrade, Serbia)
10.05-10.25 Changing Landscape of Diabetic Kidney Disease
Iasmina Craici (Rochester, USA)
10.25-10.35 Discussion
10.35-10.55 Treatment of diabetic kidney disease: what’s new
Silvia Titan (Rochester, USA)
10.55-11.05 Discussion
11.05-11.25 Prevention and treatment of diabetic kidney disease:
the position within type 2 diabetes therapeutic recommendations
Nebojsa M. Lalic (Belgrade, Serbia)
11.25-11.35 Discussion
11.35-11.55 Dialysis considerations in patients with diabetic nephropathy
Neera Dahl (Rochester, USA)
11.55-12.05 Discussion
12.05-12.25 Treg therapy for autoimmune diabetes and kidney transplantation
Nikolaos Skartsis (Rochester, USA)
12.25-12.35 Discussion
12.35-13.30 Lunch / Coffee break
Session: KIDNEY STONES IN ASSOCIATION WITH THE MAYO CLINIC PATOPHYSIOLOGY;
PREVENTION AND TREATMENT
Session chairs: Milan Radovic (Serbia), Vesna D. Garovic (USA)
13.30-13.50 Pathophysiology of kidney stones
Hatim Hassan (Rochester, USA)
13.50-14.00 Discussion
14.00-14.20 Monogenic causes of nephrocalcinosis and nephrolithiasis
John Lieske (Rochester, USA)
14.20-14.30 Discussion
14.30-14.50 What else may be made of stone in CKD patients?
Milan Radovic (Belgrade, Serbia)
14.50-15.00 Discussion
15.00-15.20 Kidney stone recurrence and the risk of chronic kidney disease
Andrew Rule (Rochester, USA)
15.20-15.30 Discussion
15.30-15.50 Kidney stones prevention: Insight from recent clinical trials
Ziad Zoghby (Rochester, USA)
15.50-16.00 Discussion
16.00-16.40 Test and Evaluation for participants
Prilog: